GB0602040D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0602040D0
GB0602040D0 GB0602040A GB0602040A GB0602040D0 GB 0602040 D0 GB0602040 D0 GB 0602040D0 GB 0602040 A GB0602040 A GB 0602040A GB 0602040 A GB0602040 A GB 0602040A GB 0602040 D0 GB0602040 D0 GB 0602040D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0602040A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0602040A priority Critical patent/GB0602040D0/en
Publication of GB0602040D0 publication Critical patent/GB0602040D0/en
Priority to CN2006800451692A priority patent/CN101321736B/en
Priority to PCT/GB2006/003590 priority patent/WO2007036715A2/en
Priority to KR1020137020049A priority patent/KR20130091791A/en
Priority to KR1020087007797A priority patent/KR101374458B1/en
Priority to BRPI0616609-1A priority patent/BRPI0616609A2/en
Priority to ES06794584T priority patent/ES2357970T3/en
Priority to EP06794584A priority patent/EP1943230B1/en
Priority to JP2008532866A priority patent/JP5209480B2/en
Priority to CA2624504A priority patent/CA2624504C/en
Priority to EA200801001A priority patent/EA016286B1/en
Priority to UAA200803937A priority patent/UA101299C2/en
Priority to US12/088,465 priority patent/US8283364B2/en
Priority to AT06794584T priority patent/ATE492537T1/en
Priority to DE602006019119T priority patent/DE602006019119D1/en
Priority to MYPI20080901A priority patent/MY148504A/en
Priority to NZ566508A priority patent/NZ566508A/en
Priority to AU2006296369A priority patent/AU2006296369B2/en
Priority to JO2006342A priority patent/JO2634B1/en
Priority to PE2006001183A priority patent/PE20070490A1/en
Priority to ARP060104268A priority patent/AR056103A1/en
Priority to TW095135887A priority patent/TWI389905B/en
Priority to US11/852,455 priority patent/US8481566B2/en
Priority to IL190219A priority patent/IL190219A/en
Priority to MA30812A priority patent/MA29849B1/en
Priority to CR9904A priority patent/CR9904A/en
Priority to NO20081945A priority patent/NO20081945L/en
Priority to ZA200802167A priority patent/ZA200802167B/en
Ceased legal-status Critical Current

Links

GB0602040A 2005-09-30 2006-02-01 Compounds Ceased GB0602040D0 (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
GB0602040A GB0602040D0 (en) 2006-02-01 2006-02-01 Compounds
AU2006296369A AU2006296369B2 (en) 2005-09-30 2006-09-27 Compounds which have activity at M1 receptor and their uses in medicine
US12/088,465 US8283364B2 (en) 2005-09-30 2006-09-27 Compounds which have activity at M1 receptor and their uses in medicine
DE602006019119T DE602006019119D1 (en) 2005-09-30 2006-09-27 COMPOUNDS WITH ACTIVITY AT THE M1 RECEPTOR AND THEIR USE IN MEDICINE
KR1020137020049A KR20130091791A (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
KR1020087007797A KR101374458B1 (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
BRPI0616609-1A BRPI0616609A2 (en) 2005-09-30 2006-09-27 compounds having m1 receptor activity, pharmaceutical composition containing such compounds, processes for their preparation, as well as their uses in medicine
ES06794584T ES2357970T3 (en) 2005-09-30 2006-09-27 COMPOUNDS THAT HAVE ACTIVITY IN THE RECEIVER M1 AND ITS USES IN MEDICINE.
EP06794584A EP1943230B1 (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
JP2008532866A JP5209480B2 (en) 2005-09-30 2006-09-27 Compounds having activity at the M1 receptor and their use in medicine
CA2624504A CA2624504C (en) 2005-09-30 2006-09-27 Benzimidazolone compounds which have activity at m1 receptor and their uses in medicine
EA200801001A EA016286B1 (en) 2005-09-30 2006-09-27 Compounds which have activity at mreceptor and their uses in medicine
UAA200803937A UA101299C2 (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
CN2006800451692A CN101321736B (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
AT06794584T ATE492537T1 (en) 2005-09-30 2006-09-27 COMPOUNDS WITH M1 RECEPTOR ACTIVITY AND THEIR USE IN MEDICINE
PCT/GB2006/003590 WO2007036715A2 (en) 2005-09-30 2006-09-27 Compounds which have activity at m1 receptor and their uses in medicine
MYPI20080901A MY148504A (en) 2005-09-30 2006-09-27 Compounds which have activity at m? receptor and their uses in medicine
NZ566508A NZ566508A (en) 2005-09-30 2006-09-27 Benzimidazole derivatives which have activity at M1 receptor and their uses in medicine
TW095135887A TWI389905B (en) 2005-09-30 2006-09-28 Compounds which have activity at m1receptor and their uses in medicine
JO2006342A JO2634B1 (en) 2005-09-30 2006-09-28 Compounds which have activity at M1 receptor and their uses in medicine
PE2006001183A PE20070490A1 (en) 2005-09-30 2006-09-28 BENZYMIDAZOLE-2-ONA DERIVATIVE COMPOUNDS SUBSTITUTED WITH PIPERIDINE AS MUSCARINE M1 RECEPTOR AGONISTS
ARP060104268A AR056103A1 (en) 2005-09-30 2006-09-28 COMPOUNDS OF (PIRAN-PIPERIDINIL) BENZIMIDAZOL, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PREPARATION PROCESS AND USES IN THE TREATMENT OF AFFECTIONS MEDIATED BY AGONISTS OF MUSCARINIC RECEIVER M1
US11/852,455 US8481566B2 (en) 2005-09-30 2007-09-10 Compounds which have activity at M1 receptor and their uses in medicine
IL190219A IL190219A (en) 2005-09-30 2008-03-17 Compounds which have activity at m1 receptor, pharmaceutical compositions comprising them, process for their preparation and use thereof in the manufacture of medicaments
MA30812A MA29849B1 (en) 2005-09-30 2008-04-04 COMPOUNDS EXERCISING AN ACTIVITY AT THE M1 RECEPTOR LEVEL AND THEIR USES IN MEDICINE
CR9904A CR9904A (en) 2005-09-30 2008-04-18 Compounds that have activity in the M1 receptor and their uses in medicine
NO20081945A NO20081945L (en) 2005-09-30 2008-04-23 Compounds that have activity as M1 receptor and their medical use
ZA200802167A ZA200802167B (en) 2005-09-30 2009-03-07 Compounds which have activity at M1 Receptor and their uses in medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0602040A GB0602040D0 (en) 2006-02-01 2006-02-01 Compounds

Publications (1)

Publication Number Publication Date
GB0602040D0 true GB0602040D0 (en) 2006-03-15

Family

ID=36100859

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0602040A Ceased GB0602040D0 (en) 2005-09-30 2006-02-01 Compounds

Country Status (2)

Country Link
ES (1) ES2357970T3 (en)
GB (1) GB0602040D0 (en)

Also Published As

Publication number Publication date
ES2357970T3 (en) 2011-05-04

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0605786D0 (en) Compounds
GB0606876D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
GB0607175D0 (en) Compounds
GB0605784D0 (en) Compounds
GB0605785D0 (en) Compounds
EP2082022A4 (en) Compounds
GB0606913D0 (en) Compounds
GB0602042D0 (en) Compounds
EP2004174A4 (en) Naphthalenedione compounds
EP1973905A4 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (en) Bis-pyridinium compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0602856D0 (en) Compounds
GB0605414D0 (en) Compounds
GB0602558D0 (en) Compounds
GB0602559D0 (en) Compounds
GB0602454D0 (en) Compounds
GB0602853D0 (en) Compounds
GB0602451D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)